Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]

In a new study, researchers report that they have dramatically broadened the potential targets of CAR-T therapy – their engineered T-cells attack a variety of solid-tumour cancer cells from humans and mice.

A study led by the Institut de Neurociències (INc-UAB) describes a new strategy to tackle cancer, based on inducing a potent stress in tumour causing cell destruction by autophagy.

Changes to the gut microbiome interacted with the immune system to slow the growth of cancer in mice exposed to cigarette smoke, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2020.

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumours.